Product Information

PRALUENT 150 MG/ML PEN is a brand product labeled by Regeneron Pharmaceuticals, Inc., priced at $258.0202 per ML under NDC 61755002102. Its NADAC has been published 279 times since Jul 21, 2021.

PRALUENT 150 MG/ML PEN

alirocumab
$258.0202per ML

Strength

150 mg/mL

NDC

61755002102

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

ALIROCUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125559

On Market Since

12/1/2020

Pharmacological Classes

Antibodies
Monoclonal
PCSK9 Inhibitor
PCSK9 Inhibitors

Price Statistics

The NADAC for PRALUENT 150 MG/ML PEN has been published 279 times since Jul 21, 2021, and over the history we have for it it has risen 18.6%. The table below summarizes its recorded NADAC range and movement.

Current price$258.0202 per ML
All-time high$258.1639 (May 13, 2026)
All-time low$217.5943 (Jul 21, 2021)
52-week high$258.1639
52-week low$250.6470
Median price$244.0428
Average price$241.5905
Largest weekly change+3.0% (Jul 27, 2022)
Weeks tracked279
Tracking sinceJul 21, 2021

Price History

1W

-0.0%

1M

+0.0%

3M

-0.0%

6M

+0.0%

1Y

+2.9%

3Y

+8.3%

5Y

+14.6%

All

+18.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the alirocumab market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PRALUENT 150 MG/ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for PRALUENT 150 MG/ML PEN, manufactured by Regeneron Pharmaceuticals, Inc., is $258.0202 per ML (NDC 61755002102), effective Nov 18, 2026.

How has the price of PRALUENT 150 MG/ML PEN changed over time?

Over the history we have for it, the NADAC for PRALUENT 150 MG/ML PEN has risen 18.6%. It has been tracked across 279 weekly CMS publications since Jul 21, 2021.

What are the highest and lowest recorded NADAC prices for PRALUENT 150 MG/ML PEN?

Since Jul 21, 2021, the NADAC for PRALUENT 150 MG/ML PEN has ranged from a low of $217.5943 (Jul 21, 2021) to a high of $258.1639 (May 13, 2026), with a median of $244.0428 per ML.

Are there cheaper alternatives to PRALUENT 150 MG/ML PEN?

No other NADAC-published product currently shares the active ingredient and strength of PRALUENT 150 MG/ML PEN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PRALUENT 150 MG/ML PEN?

PRALUENT 150 MG/ML PEN (NDC 61755002102) is labeled by Regeneron Pharmaceuticals, Inc., and CMS classifies it as a brand product.